Wells Fargo & Company Forecasts Strong Price Appreciation for Lam Research (NASDAQ:LRCX) Stock

Lam Research (NASDAQ:LRCX) had its price target lifted by Wells Fargo & Company from $98.00 to $135.00 in a report released on Thursday morning,MarketScreener reports. Wells Fargo & Company currently has an equal weight rating on the semiconductor company’s stock.

LRCX has been the subject of several other reports. Rothschild & Co Redburn boosted their price target on Lam Research from $115.00 to $140.00 and gave the company a “buy” rating in a research note on Wednesday. Mizuho lifted their price objective on Lam Research from $120.00 to $130.00 and gave the company an “outperform” rating in a report on Friday, September 12th. Stifel Nicolaus upped their target price on Lam Research from $92.00 to $110.00 and gave the company a “buy” rating in a research report on Tuesday, July 29th. Wall Street Zen lowered Lam Research from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Finally, Citigroup boosted their price target on Lam Research from $113.00 to $120.00 and gave the company a “buy” rating in a research note on Monday, September 8th. Twenty-three analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, Lam Research presently has a consensus rating of “Moderate Buy” and an average target price of $119.20.

Lam Research Stock Down 0.8%

Shares of LRCX stock opened at $145.81 on Thursday. Lam Research has a 52-week low of $56.32 and a 52-week high of $147.91. The stock has a market cap of $183.87 billion, a price-to-earnings ratio of 35.05, a PEG ratio of 1.78 and a beta of 1.84. The firm’s 50-day moving average is $110.47 and its 200-day moving average is $92.37. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.12. The business had revenue of $5.17 billion for the quarter, compared to analyst estimates of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. Lam Research’s revenue for the quarter was up 33.6% compared to the same quarter last year. During the same period last year, the firm earned $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Sell-side analysts predict that Lam Research will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th will be given a $0.26 dividend. This is an increase from Lam Research’s previous quarterly dividend of $0.23. The ex-dividend date is Wednesday, September 24th. This represents a $1.04 annualized dividend and a yield of 0.7%. Lam Research’s dividend payout ratio is currently 25.00%.

Hedge Funds Weigh In On Lam Research

Hedge funds have recently modified their holdings of the business. IMG Wealth Management Inc. bought a new position in Lam Research during the 2nd quarter worth $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research in the second quarter valued at about $27,000. Strategic Wealth Investment Group LLC acquired a new stake in shares of Lam Research in the second quarter valued at about $29,000. Delos Wealth Advisors LLC bought a new position in shares of Lam Research during the second quarter worth about $30,000. Finally, REAP Financial Group LLC acquired a new position in shares of Lam Research in the second quarter worth approximately $31,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.